Blood glucose related adverse drug reaction of antitumor monoclonal antibodies: a retrospective analysis using Vigibase
Author:
Affiliation:
1. Chinese Academy of Medical Sciences and Peking Union Medical College, China
2. Chinese Academy of Medical Sciences & Peking Union Medical College, China
Publisher
FapUNIFESP (SciELO)
Reference20 articles.
1. Diagnoses and Management of Drug Hypersensitivity and Anaphylaxis in Cancer and Chronic Inflammatory Diseases: Reactions to Taxanes and Monoclonal Antibodies;Bonamichi-Santos R;Clin Rev Allergy Immunol,2018
2. Hyperglycemia during chemotherapy for hematologic and solid tumors is correlated with increased toxicity;Brunello A;Am J ClinOncol,2011
3. The prevalence and impact of hyperglycemia and hyperlipidemia in patients with advanced cancer receiving combination treatment with the mammalian target of rapamycin inhibitor temsirolimus and insulin growth factor-receptor antibody cixutumumab;Busaidy NL;Oncologist,2015
4. Glucose tolerance status and 20 year cancer incidence;Dankner R;Isr Med Assoc J,2007
5. Emerging role of insulin-like growth factor receptor inhibitors in oncology: early clinical trial results and future directions;Gualberto A;Oncogene,2009
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Long-Acting Strategies for Antibody Drugs: Structural Modification, Controlling Release, and Changing the Administration Route;European Journal of Drug Metabolism and Pharmacokinetics;2024-04-18
2. Comprehensive Analysis of Diabetes Mellitus-related Gene Expression and Associated Prognoses in Human Lung Cancer;Current Cancer Drug Targets;2023-12
3. Uncovering Knowledge Gaps in the Safety Profile of Antiangiogenic Drugs in Cancer Patients: Insights from Spontaneous Reporting Systems Studies;Pharmaceuticals;2023-06-12
4. Machine Learning for Predicting Hyperglycemic Cases Induced by PD-1/PD-L1 Inhibitors;Journal of Healthcare Engineering;2022-08-19
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3